Neuroprotective and anti-inflammatory properties of a coffee component in the MPTP model of Parkinson's disease - Wikidata - awgldk - TriplyDB

Neuroprotective and anti-inflammatory properties of a coffee component in the MPTP model of Parkinson's disease

Neuroprotective and anti-inflammatory properties of a coffee component in the MPTP model of Parkinson's disease

http://www.wikidata.org/entity/Q24630237

about

Therapeutic benefits of a component of coffee in a rat model of Alzheimer's disease.Sulforaphane protects against rotenone-induced neurotoxicity in vivo: Involvement of the mTOR, Nrf2, and autophagy pathways.Protein Kinases and Parkinson's Disease Parkinson's disease-implicated kinases in the brain; insights into disease pathogenesis.Influence of the Form of Administration of Chlorogenic Acids on Oxidative Stress Induced by High fat Diet in Rats.Chronic caffeine ingestion causes microglia activation, but not proliferation in the healthy brain Secreted miR-34a in astrocytic shedding vesicles enhanced the vulnerability of dopaminergic neurons to neurotoxins by targeting Bcl-2 The Benefit of Bone Health by Drinking Coffee among Korean Postmenopausal Women: A Cross-Sectional Analysis of the Fourth & Fifth Korea National Health and Nutrition Examination Surveys Caffeine administration prevents retinal neuroinflammation and loss of retinal ganglion cells in an animal model of glaucoma.Pramipexole restores depressed transmission in the ventral hippocampus following MPTP-lesion.Current evidence for the use of coffee and caffeine to prevent age-related cognitive decline and Alzheimer's disease.Ligands for Ser/Thr phosphoprotein phosphatases: a patent review (2005-2015).Inhibition of protein methylesterase 1 decreased cancerous phenotypes in endometrial adenocarcinoma cell lines and xenograft tumor models.Protein Phosphatase 2A: a Double-Faced Phosphatase of Cellular System and Its Role in Neurodegenerative Disorders.Having a Coffee Break: The Impact of Caffeine Consumption on Microglia-Mediated Inflammation in Neurodegenerative Diseases.The Neuroprotective Effect of Dimethyl Fumarate in an MPTP-Mouse Model of Parkinson's Disease: Involvement of Reactive Oxygen Species/Nuclear Factor-κB/Nuclear Transcription Factor Related to NF-E2.Isolation and quantification of major chlorogenic acids in three major instant coffee brands and their potential effects on H2O2-induced mitochondrial membrane depolarization and apoptosis in PC-12 cells.Protein Phosphatase 2A and Its Methylation Modulating Enzymes LCMT-1 and PME-1 Are Dysregulated in Tauopathies of Progressive Supranuclear Palsy and Alzheimer Disease.Eicosanoyl-5-hydroxytryptamide (EHT) prevents Alzheimer's disease-related cognitive and electrophysiological impairments in mice exposed to elevated concentrations of oligomeric beta-amyloid.Effects of Agmatine on Depressive-Like Behavior Induced by Intracerebroventricular Administration of 1-Methyl-4-phenylpyridinium (MPP(+)).Multiple mechanisms of dimethyl fumarate in amyloid β-induced neurotoxicity in human neuronal cells.Plant-Derived Natural Products for Parkinson's Disease Therapy.Beneficial Role of Coffee and Caffeine in Neurodegenerative Diseases: A Minireview.Caffeine Protects Dopaminergic Neurons From Dopamine-Induced Neurodegeneration via Synergistic Adenosine-Dopamine D2-Like Receptor Interactions in Transgenic Caenorhabditis elegans.JNK-mediated microglial DICER degradation potentiates inflammatory responses to induce dopaminergic neuron loss.

P2860

Q24563378-54110F89-880B-4027-8EA8-A9935A4AEBDC Q27314642-F197AFF4-38D0-49AA-BB50-822E4E0DD9BA Q28067636-779E0207-70CD-4911-B3F2-55BC595B8679 Q33797449-6F600AF7-B317-47FE-B5C2-826721E8324D Q33841740-C39CF29D-EE18-4B9D-B624-D9493832FE1E Q33954408-0FDA3E8A-881F-45FA-B86D-3567640636FC Q35816071-53E6022A-06B4-41DF-A235-6379C1FBEFF0 Q35905748-12642888-393E-4920-B59E-00BC72DFECFF Q36043139-38246D59-375F-474E-AE41-82F1AA69F2A4 Q37698828-DB89B3EC-0EDF-478D-99C1-17BD3574555C Q38199970-0E3EEC6C-B010-4655-9CA3-5A0E1B11D05E Q38725557-5BE90F9D-B997-49F0-8563-27695BAAE526 Q38737146-A532C23B-F57B-4106-BFF4-973C89C234A5 Q39146231-7C00F572-5CF3-4BC2-BEF5-CD9C19061748 Q39157059-6B25903A-B9C8-4EBA-9279-A5E2FC21E57C Q41467663-8BA84DAB-1B37-449B-AF60-BEBF2299EACC Q46991155-7ADFBF8E-DA69-465E-853B-40A061C4C015 Q47252033-62C7BC1D-68E4-480A-8B13-CAB4D4226C33 Q47279111-02802AFB-77F5-4BFE-AA64-FC2EDCA66D09 Q48078497-6AF7BE62-5FBB-4739-87F4-4C0AF463D63F Q48223070-A43C707D-635C-448F-A915-61CA8DB59D01 Q51800931-0DA8A36A-034E-467E-A3C4-D58FE83DA17E Q54572410-8801F32D-ABAC-4D1D-8AD1-BB3E1F2EF511 Q54975826-49A9F4DB-0764-455B-BB97-46EAE6345BE7 Q55419599-825C8417-7ED7-41E4-930A-D03CA1A770CF

P2860

Neuroprotective and anti-inflammatory properties of a coffee component in the MPTP model of Parkinson's disease

http://www.wikidata.org/entity/Q24630237

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Neuroprotective and anti-infla ...... P model of Parkinson's disease

@ast

Neuroprotective and anti-infla ...... P model of Parkinson's disease

@en

Neuroprotective and anti-infla ...... P model of Parkinson's disease

@nl

type

label

Neuroprotective and anti-infla ...... P model of Parkinson's disease

@ast

Neuroprotective and anti-infla ...... P model of Parkinson's disease

@en

Neuroprotective and anti-infla ...... P model of Parkinson's disease

@nl

prefLabel

Neuroprotective and anti-infla ...... P model of Parkinson's disease

@ast

Neuroprotective and anti-infla ...... P model of Parkinson's disease

@en

Neuroprotective and anti-infla ...... P model of Parkinson's disease

@nl

P1433

Q24630237-B1352766-23F0-48C6-A053-6C5914C4B117

P1476

Q24630237-3B50AEBA-EDF4-4A2A-A48E-E1DF9FA18412

P2093

Q24630237-10954EED-F54D-4E98-A693-B1C03D5E2657

Q24630237-189426EA-9490-4B6D-9F4B-DC14743EF4F2

Q24630237-1ECA156A-EED9-44F1-B00C-3F99E94D5D43

Q24630237-34572C6D-74FE-4614-820E-9133E48BF255

Q24630237-3CC8370C-47F5-4EFF-9E02-2C0534C72ADF

Q24630237-4E54829C-C725-483E-A208-ECE746AEF20C

Q24630237-5A4E79DB-4E05-4279-9EEE-36B2223769BD

Q24630237-69DC325F-5AC3-489B-8F1B-8915701AFA7A

Q24630237-7F55968B-EDD4-491D-98AB-AF644C40317E

Q24630237-83AFB3D0-2690-445B-92E6-F7CD872DB981

P2860

Q24630237-029457D3-7B34-4C0A-9E58-496B1F99841F

Q24630237-06206938-0A49-4378-B946-82F002E7884D

Q24630237-06F84540-47A8-4C13-BADC-32D28CA8A407

Q24630237-07AAEEA1-EA4B-47A4-B426-E27693B38223

Q24630237-08209234-A429-4D9C-853B-C77707534E3A

Q24630237-0B03F44D-2FBC-4B05-8AFD-A9BD0872CA95

Q24630237-0CC052BE-9EF2-4E3A-88D5-A826BB72133B

Q24630237-100DAF4F-94F3-4B9D-98BA-BF873C705E6C

Q24630237-10EE28C2-53FE-42E5-916A-487AD4090647

Q24630237-155E6B9A-6AAD-42C8-A492-4B9A7485A67B

P2888

Q24630237-C17A9FE4-67D0-4607-AEBA-037ED4A03F1F

P304

Q24630237-25745947-4CA7-463A-B3E5-2B14CBED9D8C

P31

Q24630237-6BF9C53F-5726-4464-9BCE-C53ACA5922B7

P3181

Q24630237-5AD3348A-FFDC-48B5-8B78-20DF6FAB5B1F

P356

Q24630237-8C022075-7A62-41D2-8270-6983B90E474A

P407

Q24630237-1980893B-E6B6-4FD7-A01A-55C275087ACC

P433

Q24630237-9062B4A9-6198-430F-BDD6-4F87BCA570CC

P478

Q24630237-D813F117-38D7-4009-8982-97AA40749684

P577

Q24630237-53EC6E36-A582-4DDE-9FDF-047A7AB576A2

P5875

Q24630237-7119F706-3CBA-4ABF-9F59-E3FBE0ABB954

P6179

Q24630237-AC1978CC-854D-4CEE-BAE4-C8EDC01419AF

P698

Q24630237-64F71716-6B45-4F64-96FE-F62A195F8A48

P921

Q24630237-103683A2-6356-47FD-9EC5-9C3CC279914B

Q24630237-37134B4D-CDE9-4B97-AFD7-CE1BDA5C3BD4

P932

Q24630237-7BBD453F-D25E-4129-82DC-7BD9CAFFB249

P3181

P356

S13311-012-0165-2

P1433

Neurotherapeutics

P1476

Neuroprotective and anti-infla ...... P model of Parkinson's disease

@en

P2093

Ana Clara Cristovao

http://www.w3.org/2001/XMLSchema#string

David S Schuster

http://www.w3.org/2001/XMLSchema#string

Eunsung Junn

http://www.w3.org/2001/XMLSchema#string

Hilary Grosso

http://www.w3.org/2001/XMLSchema#string

Jeffry B Stock

http://www.w3.org/2001/XMLSchema#string

Jong-Min Woo

http://www.w3.org/2001/XMLSchema#string

Joo-Young Im

http://www.w3.org/2001/XMLSchema#string

Jose R Fernandez

http://www.w3.org/2001/XMLSchema#string

Kang-Woo Lee

http://www.w3.org/2001/XMLSchema#string

M Maral Mouradian

http://www.w3.org/2001/XMLSchema#string

P2860

Type 2A protein phosphatase, the complex regulator of numerous signaling pathways

Constitutive induction of p-Erk1/2 accompanied by reduced activities of protein phosphatases 1 and 2A and MKP3 due to reactive oxygen species during cellular senescence

Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling

Association of coffee drinking with total and cause-specific mortality

Phosphoprotein phosphatase 2A: a novel druggable target for Alzheimer's disease

Microglia-mediated neurotoxicity: uncovering the molecular mechanisms

Neuroinflammation in Parkinson's disease: a target for neuroprotection?

Oxidative stress in Parkinson's disease

Unbiased stereological estimation of the total number of neurons in thesubdivisions of the rat hippocampus using the optical fractionator

Caffeine and progression of Parkinson disease

P2888

s13311-012-0165-2

P304

143-53

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

949085

http://www.w3.org/2001/XMLSchema#string

P356

10.1007/S13311-012-0165-2

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

234086612

http://www.w3.org/2001/XMLSchema#string

P6179

1049659055

http://www.w3.org/2001/XMLSchema#string

P698

23296837

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

3557367

http://www.w3.org/2001/XMLSchema#string